Is this study's primary condition wrong?
An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis
- The registry's first term
- Bacterial Infections
- ClinicalTrials.gg shows
- Anthrax
An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis